Effect of prednisolone on the primary immunologic response

1969 ◽  
Vol 68 (4) ◽  
pp. 1133-1134
Author(s):  
L. S. Uteshev ◽  
B. V. Pinegin ◽  
A. G. Kalinkovich ◽  
V. V. Lebedev
Keyword(s):  
Immunologic Response ◽  
Primary Immunologic Response

Morphological and submicroscopic characteristics of the primary immunologic response after destruction of the posterior hypothalamic nuclei

1975 ◽  
Vol 79 (1) ◽  
pp. 78-82 ◽  
Author(s):  
O. V. Kishkovskaya ◽  
K. A. Zufarov ◽  
B. A. Saakov ◽  
A. I. Polyak
Keyword(s):  
Immunologic Response ◽  
Hypothalamic Nuclei ◽  
Primary Immunologic Response

Primary immunologic response in neonatally thymectomized mice

1968 ◽  
Vol 65 (1) ◽  
pp. 73-75
Author(s):  
S. N. Zinzar
Keyword(s):  
Immunologic Response ◽  
Thymectomized Mice ◽  
Primary Immunologic Response

scholarly journals Effect of HIV‐1 Subtype on Virologic and Immunologic Response to Starting Highly Active Antiretroviral Therapy

2009 ◽  
Vol 48 (9) ◽  
pp. 1296-1305 ◽  
Author(s):  
Anna Maria Geretti ◽  
Linda Harrison ◽  
Hannah Green ◽  
Caroline Sabin ◽  
Teresa Hill ◽  
...  
Keyword(s):  
Antiretroviral Therapy ◽  
Highly Active Antiretroviral Therapy ◽  
Immunologic Response ◽  
Highly Active ◽  
Hiv 1

scholarly journals Long-Term Safety, Immunologic Response, and Imaging Outcomes following Neural Stem Cell Transplantation for Pelizaeus-Merzbacher Disease

2019 ◽  
Vol 13 (2) ◽  
pp. 254-261 ◽  
Author(s):  
Nalin Gupta ◽  
Roland G. Henry ◽  
Sang-Mo Kang ◽  
Jonathan Strober ◽  
Daniel A. Lim ◽  
...  
Keyword(s):  
Stem Cell ◽  
Stem Cell Transplantation ◽  
Cell Transplantation ◽  
Neural Stem Cell ◽  
Immunologic Response ◽  
Pelizaeus Merzbacher Disease

A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide

Lung Cancer ◽  
2014 ◽  
Vol 86 (1) ◽  
pp. 59-66 ◽  
Author(s):  
Athanasios Kotsakis ◽  
Elisavet Papadimitraki ◽  
Eleni Kyriaki Vetsika ◽  
Despoina Aggouraki ◽  
Eleftheria Kleio Dermitzaki ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cancer Patients ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Immunologic Response ◽  
Small Cell Lung ◽  
Lung Cancer Patients ◽  
Cryptic Peptide

scholarly journals Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis

2016 ◽  
Vol 24 (1) ◽  
Author(s):  
Joshua C. Eby ◽  
Mary C. Gray ◽  
Jason M. Warfel ◽  
Tod J. Merkel ◽  
Erik L. Hewlett
Keyword(s):  
Adenylate Cyclase ◽  
Bordetella Pertussis ◽  
Neutralization Assay ◽  
Enzyme Linked Immunosorbent Assay ◽  
Immunologic Response ◽  
Serum Samples ◽  
Content Type ◽  
Adenylate Cyclase Toxin ◽  
Strong Candidate ◽  
Candidate Antigen

ABSTRACT Adenylate cyclase toxin (ACT) is an essential virulence factor of Bordetella pertussis, and antibodies to ACT protect against B. pertussis infection in mice. The toxin is therefore a strong candidate antigen for addition to future acellular pertussis vaccines. In order to characterize the functionality of the immunologic response to ACT after infection, we developed an assay for testing the ability of serum samples from subjects infected with B. pertussis to neutralize ACT-induced cytotoxicity in J774 macrophage cells. Baboons develop neutralizing anti-ACT antibodies following infection with B. pertussis, and all sera from baboons with positive anti-ACT IgG enzyme-linked immunosorbent assay (ELISA) results neutralized ACT cytotoxicity. The toxin neutralization assay (TNA) was positive in some baboon sera in which ELISA remained negative. Of serum samples obtained from humans diagnosed with pertussis by PCR, anti-ACT IgG ELISA was positive in 72%, and TNA was positive in 83%. All samples positive for anti-ACT IgG ELISA were positive by TNA, and none of the samples from humans without pertussis neutralized toxin activity. These findings indicate that antibodies to ACT generated following infection with B. pertussis consistently neutralize toxin-induced cytotoxicity and that TNA can be used to improve understanding of the immunologic response to ACT after infection or vaccination.

Elevated Tissue Immunoglobulins in Hirschsprung's Disease - Indication of Early Immunologic Response

2000 ◽  
Vol 10 (02) ◽  
pp. 106-110 ◽  
Author(s):  
S. Moore ◽  
G. Johnson ◽  
J. Schneider
Keyword(s):  
Hirschsprung's Disease ◽  
Hirschsprung’S Disease ◽  
Immunologic Response

scholarly journals The Immunologic Response to Xenografts

ILAR Journal ◽  
1995 ◽  
Vol 37 (1) ◽  
pp. 16-22 ◽  
Author(s):  
D. H. Sachs
Keyword(s):  
Immunologic Response
Sign in / Sign up

Export Citation Format

Share Document